| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Center for Biochemical and Biophysical Sciences and Medicine, Department of Pathology, Harvard Medical School, Boston, Massachusetts
Requests for reprints: Guo-fu Hu, Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, MA 02115. Phone: 617-432-6582; Fax: 617-432-6580; E-mail: guofu_hu{at}hms.harvard.edu.
Angiogenin is an angiogenic protein known to play a role in rRNA transcription in endothelial cells. Nuclear translocation of angiogenin in endothelial cells decreases as cell density increases and ceases when cells are confluent. Here we report that angiogenin is constantly translocated to the nucleus of HeLa cells in a cell densityindependent manner. Down-regulation of angiogenin expression by antisense and RNA interference results in a decrease in rRNA transcription, ribosome biogenesis, proliferation, and tumorigenesis both in vitro and in vivo. Exogenous angiogenin rescues the cells from antisense and RNA interference inhibition. The results showed that angiogenin is constitutively translocated into the nucleus of HeLa cells where it stimulates rRNA transcription. Thus, besides its angiogenic activity, angiogenin also plays a role in cancer cell proliferation.
Key Words: rRNA transcription cell proliferation cancer progression angiogenin nuclear translocation
This article has been cited by other articles:
![]() |
D. Kieran, J. Sebastia, M. J. Greenway, M. A. King, D. Connaughton, C. G. Concannon, B. Fenner, O. Hardiman, and J. H. M. Prehn Control of Motoneuron Survival by Angiogenin J. Neurosci., December 24, 2008; 28(52): 14056 - 14061. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schwartz, O. Shoseyov, V. O. Melnikova, M. McCarty, M. Leslie, L. Roiz, P. Smirnoff, G.-f. Hu, D. Lev, and M. Bar-Eli ACTIBIND, a T2 RNase, Competes with Angiogenin and Inhibits Human Melanoma Growth, Angiogenesis, and Metastasis Cancer Res., June 1, 2007; 67(11): 5258 - 5266. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshioka, L. Wang, K. Kishimoto, T. Tsuji, and G.-f. Hu A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation PNAS, September 26, 2006; 103(39): 14519 - 14524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirukawa, K. A. Olson, T. Tsuji, and G.-f. Hu Neamine Inhibits Xenografic Human Tumor Growth and Angiogenesis in Athymic Mice Clin. Cancer Res., December 15, 2005; 11(24): 8745 - 8752. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |